Literature DB >> 4046500

Treatment of resistant hypertension by phlebotomy.

W Zidek, W Tenschert, C Karoff, H Vetter.   

Abstract

In 15 essential hypertensives resistant against a standard triple combination of antihypertensive drugs phlebotomy was performed. Mean arterial pressure was lowered from 140.1 +/- 12.2 mm Hg to 123.8 +/- 14.9 mm Hg after 14 days. No serious side effects were observed. The duration of the hypotensive effect of phlebotomy was about 4 weeks. Phlebotomy can be used in addition to drug treatment in resistant essential hypertension.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4046500     DOI： 10.1007/BF01733828

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN： 0023-2173


  4 in total

Review 1.  The role of humoral agents in volume expanded hypertension.

Authors:  F J Haddy; H W Overbeck
Journal:  Life Sci       Date:  1976-10-01       Impact factor: 5.037

Review 2.  Natriuretic hormone.

Authors:  H E De Wardener
Journal:  Clin Sci Mol Med       Date:  1977-07

3.  Evidence in vivo for a circulating natriuretic substance in rats after expanding the blood volume.

Authors:  C A Knock; H E de Wardener
Journal:  Clin Sci (Lond)       Date:  1980-12       Impact factor: 6.124

4.  How diuretics lower blood pressure.

Authors:  E D Freis
Journal:  Am Heart J       Date:  1983-07       Impact factor: 4.749
  4 in total
  3 in total

1.  Bleeding-edge technology in cardiology - or the mixed blessings of phlebotomy throughout the ages.

Authors:  C van Tellingen
Journal:  Neth Heart J       Date:  2010-04       Impact factor: 2.380

2.  Effects of phlebotomy-induced reduction of body iron stores on metabolic syndrome: results from a randomized clinical trial.

Authors:  Khosrow S Houschyar; Rainer Lüdtke; Gustav J Dobos; Ulrich Kalus; Martina Broecker-Preuss; Thomas Rampp; Benno Brinkhaus; Andreas Michalsen
Journal:  BMC Med       Date:  2012-05-30       Impact factor: 8.775

3.  Bloodletting has no effect on the blood pressure abnormalities of hyperandrogenic women taking oral contraceptives in a randomized clinical trial.

Authors:  Manuel Luque-Ramírez; Andrés E Ortiz-Flores; Lía Nattero-Chávez; M Ángeles Martínez-García; María Insenser; Francisco Álvarez-Blasco; Elena Fernández-Durán; Alejandra Quintero-Tobar; Sara de Lope Quiñones; Héctor F Escobar-Morreale
Journal:  Sci Rep       Date:  2021-11-11       Impact factor: 4.379
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.